March 5, 2022 Comments Off on New patent for Mylan Ireland drug YUPELRI Posted in: Patent Added Annual Drug Patent Expirations for YUPELRI Yupelri is a drug marketed by Mylan Ireland Ltd and is included in one NDA. It is available from one supplier. There are fifteen…
The post New patent for Mylan Ireland drug YUPELRI appeared first on DrugPatent…
March 4, 2022 Comments Off on New patent for MIRUM drug LIVMARLI Posted in: Patent Added Annual Drug Patent Expirations for LIVMARLI Livmarli is a drug marketed by Mirum and is included in one NDA. The generic ingredient in LIVMARLI is maralixibat chloride. Additional details are…
The post New patent for MIRUM drug LIVMARLI appeared first …